Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
16.5M
-
Shares change
-
-2.3M
-
Total reported value, excl. options
-
$23.1M
-
Value change
-
-$4.05M
-
Put/Call ratio
-
0.22
-
Number of buys
-
10
-
Number of sells
-
-19
-
Price
-
$1.40
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q3 2023
51 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q3 2023.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.5M shares
of 52.3M outstanding shares and own 31.59% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.18M shares), RENAISSANCE TECHNOLOGIES LLC (2.56M shares), TANG CAPITAL MANAGEMENT LLC (2.2M shares), VANGUARD GROUP INC (1.73M shares), Potomac Capital Management, Inc. (1.46M shares), BlackRock Inc. (955K shares), DIMENSIONAL FUND ADVISORS LP (843K shares), GEODE CAPITAL MANAGEMENT, LLC (338K shares), RBF Capital, LLC (250K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (227K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.